Skip to main content
. Author manuscript; available in PMC: 2017 Sep 13.
Published in final edited form as: ACS Chem Neurosci. 2016 May 17;7(7):984–994. doi: 10.1021/acschemneuro.6b00098

Figure 1.

Figure 1

Amino acid sequence of the endogenous POMC melanocortin agonists and NDP-MSH synthetic analog. The numbering of α-MSH is indicated. The tetrapeptide sequence His-Phe-Arg-Trp, common to all naturally occurring MCR agonists, is indicated in bold. The more potent NDP-MSH ligand is modified from α-MSH by replacing Met4 with Nle and inverting the stereochemistry at the Phe7 position.